GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (STU:6YC) » Definitions » Common Stock

Senzime AB (STU:6YC) Common Stock : €1.32 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Senzime AB Common Stock?

Senzime AB's quarterly common stock increased from Mar. 2024 (€1.32 Mil) to Jun. 2024 (€1.33 Mil) but then declined from Jun. 2024 (€1.33 Mil) to Sep. 2024 (€1.32 Mil).

Senzime AB's annual common stock increased from Dec. 2021 (€0.76 Mil) to Dec. 2022 (€0.80 Mil) and increased from Dec. 2022 (€0.80 Mil) to Dec. 2023 (€1.34 Mil).


Senzime AB Common Stock Historical Data

The historical data trend for Senzime AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Common Stock Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.77 0.76 0.80 1.34

Senzime AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.34 1.32 1.33 1.32

Senzime AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Senzime AB Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.

Senzime AB Headlines

No Headlines